These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36440399)

  • 41. CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.
    Müller-Vahl KR; Pisarenko A; Szejko N; Haas M; Fremer C; Jakubovski E; Musil R; Münchau A; Neuner I; Huys D; van Elst LT; Schröder C; Ringlstetter R; Koch A; Jenz EB; Großhennig A
    Psychiatry Res; 2023 May; 323():115135. PubMed ID: 36878177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Correlates of Health-Related Quality of Life in Adults With Chronic Tic Disorder.
    Isaacs DA; Riordan HR; Claassen DO
    Front Psychiatry; 2021; 12():619854. PubMed ID: 33776814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of a modified comprehensive behavioral intervention for tics for children and adolescents with tourette's syndrome: A randomized controlled trial.
    Chen CW; Wang HS; Chang HJ; Hsueh CW
    J Adv Nurs; 2020 Mar; 76(3):903-915. PubMed ID: 31782167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavior therapy for children with Tourette disorder: a randomized controlled trial.
    Piacentini J; Woods DW; Scahill L; Wilhelm S; Peterson AL; Chang S; Ginsburg GS; Deckersbach T; Dziura J; Levi-Pearl S; Walkup JT
    JAMA; 2010 May; 303(19):1929-37. PubMed ID: 20483969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
    Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
    BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review.
    Whittington C; Pennant M; Kendall T; Glazebrook C; Trayner P; Groom M; Hedderly T; Heyman I; Jackson G; Jackson S; Murphy T; Rickards H; Robertson M; Stern J; Hollis C
    J Child Psychol Psychiatry; 2016 Sep; 57(9):988-1004. PubMed ID: 27132945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current controversies on the role of behavior therapy in Tourette syndrome.
    Scahill L; Woods DW; Himle MB; Peterson AL; Wilhelm S; Piacentini JC; McNaught K; Walkup JT; Mink JW
    Mov Disord; 2013 Aug; 28(9):1179-83. PubMed ID: 23681719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CBIT+TMS Trial: study protocol for a two-phase randomized controlled trial testing neuromodulation to augment behavior therapy for youth with chronic tics.
    Conelea C; Greene D; Alexander J; Houlihan K; Hodapp S; Wellen B; Francis S; Mueller B; Hendrickson T; Tseng A; Chen M; Fiecas M; Lim K; Opitz A; Jacob S
    Res Sq; 2023 Jun; ():. PubMed ID: 37398344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated cognitive behavioral intervention for functional tics (I-CBiT): case reports and treatment formulation.
    Maxwell A; Zouki JJ; Eapen V
    Front Pediatr; 2023; 11():1265123. PubMed ID: 38034832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized trial of behavior therapy for adults with Tourette syndrome.
    Wilhelm S; Peterson AL; Piacentini J; Woods DW; Deckersbach T; Sukhodolsky DG; Chang S; Liu H; Dziura J; Walkup JT; Scahill L
    Arch Gen Psychiatry; 2012 Aug; 69(8):795-803. PubMed ID: 22868933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of gender on Tourette syndrome beyond adolescence.
    Lichter DG; Finnegan SG
    Eur Psychiatry; 2015 Feb; 30(2):334-40. PubMed ID: 25193042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deutetrabenazine in Tics Associated with Tourette Syndrome.
    Jankovic J; Jimenez-Shahed J; Budman C; Coffey B; Murphy T; Shprecher D; Stamler D
    Tremor Other Hyperkinet Mov (N Y); 2016; 6():422. PubMed ID: 27917309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted Interventions in Tourette's using Advanced Neuroimaging and Stimulation (TITANS): study protocol for a double-blind, randomised controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area in children with Tourette's syndrome.
    Kahl CK; Swansburg R; Kirton A; Pringsheim T; Wilcox G; Zewdie E; Harris A; Croarkin PE; Nettel-Aguirre A; Chenji S; MacMaster FP
    BMJ Open; 2021 Dec; 11(12):e053156. PubMed ID: 34952879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining tic severity and tic impairment in Tourette Disorder.
    McGuire JF; Piacentini J; Storch EA; Ricketts EJ; Woods DW; Peterson AL; Walkup JT; Wilhelm S; Ramsey K; Essoe JK; Himle MB; Lewin AB; Chang S; Murphy TK; McCracken JT; Scahill L
    J Psychiatr Res; 2021 Jan; 133():93-100. PubMed ID: 33338735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychosocial stress in children with Tourette syndrome and chronic tic disorder.
    Tan CY; Chiu NC; Zeng YH; Huang JY; Tzang RF; Chen HJ; Lin YJ; Sun FJ; Ho CS
    Pediatr Neonatol; 2024 Jul; 65(4):336-340. PubMed ID: 38000929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders.
    Murphy TK; Fernandez TV; Coffey BJ; Rahman O; Gavaletz A; Hanks CE; Tillberg CS; Gomez LI; Sukhodolsky DG; Katsovich L; Scahill L
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):762-770. PubMed ID: 28723227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-sectional investigation of quality of life determinants among children with tic disorders: The roles of family environmental and clinical factors.
    Liu F; Wang G; Yao B; Ye J; Wang J; Wang H; Liu H
    Heliyon; 2023 Feb; 9(2):e13228. PubMed ID: 36785827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urge intolerance predicts tic severity and impairment among adults with Tourette syndrome and chronic tic disorders.
    Ramsey KA; De Nadai AS; Espil FM; Ricketts E; Stiede JT; Schild J; Specht MW; Woods DW; Bennet S; Walkup JT; Chang S; Piacentini J; McGuire JF
    Front Psychiatry; 2022; 13():929413. PubMed ID: 36032236
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study.
    Haas M; Jakubovski E; Fremer C; Dietrich A; Hoekstra PJ; Jäger B; Müller-Vahl KR;
    Front Psychiatry; 2021; 12():626459. PubMed ID: 33716826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
    Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander J; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2128204. PubMed ID: 34609495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.